Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Testicular Nonseminomatous Germ Cell Tumor, NOS clinical trials

1 of 1 indexed Testicular Nonseminomatous Germ Cell Tumor, NOS trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Testicular Nonseminomatous Germ Cell Tumor, NOS: 1 US clinical trial tracked, 1 recruiting.

Testicular Nonseminomatous Germ Cell Tumor, NOS is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Eastern Cooperative Oncology Group, running 1 of these trials.

Enrollment posture brief

Registry condition testicular-nonseminomatous-germ-cell-tumor-nos

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Testicular Nonseminomato (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Testicular Nonseminomatous Germ Cell Tumor, NOS

Testicular Nonseminomatous Germ Cell Tumor, NOS lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Testicular Nonseminomatous Germ Cell Tumor, NOS on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Testicular Nonseminomatous Germ Cell Tumor, NOS is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Testicular Nonseminomatous Germ Cell Tumor, NOS records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Questionnaires Other
1 trials

US sites by state

Facility locations filed on Testicular Nonseminomatous Germ Cell Tumor, NOS trials. A trial with sites in several states counts in each.

California 1 trials
Arizona 1 trials
Arkansas 1 trials
Alaska 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Testicular Nonseminomatous Germ Cell Tumor, NOS page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Testicular Nonseminomatous Germ Cell Tumor, NOS trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Eastern Cooperative Oncology Group sponsors the most Testicular Nonseminomatous Germ Cell Tumor, NOS trials on record, review their full trial history before evaluating a specific study. See Eastern Cooperative Oncology Group's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Testicular Nonseminomatous Germ Cell Tumor, NOS condition card totals 1 registered trials; most-linked intervention Questionnaires; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.